Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Metaproterenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 16/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.83 |
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | APEX1 | P27695 | 1/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.64 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | HTR2A | P28223 | 1/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metaproterenol SCHEMBL4270 | 1.00 | ADRB2 (1.00) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL4271 | 1.00 | ADRB2 (1.00) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL4451598 | 1.00 | ADRB2 (1.00) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL6141868 | 0.98 | ADRB2 (0.96) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL28921966 | 0.98 | ADRB2 (0.96) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL5682997 | 0.98 | ADRB2 (0.96) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL9614523 | 0.91 | MEN1 (1.00) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL15392269 | 0.91 | ADRB2 (0.83) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL41816 | 0.91 | MEN1 (1.00) | ADRB2TSHRHIF1AADRA1AMEN1 | |
| Metaproterenol SCHEMBL3049439 | 0.91 | MEN1 (1.00) | ADRB2TSHRHIF1AADRA1AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723065-B2 | Conditions for reactions mediated by yeast | VICTORIA UNIVERSITY (AU) | 2010-05-25 | — | — | US | disclosed |
| US-7723065-B2 | Conditions for reactions mediated by yeast | VICTORIA UNIVERSITY (AU) | 2010-05-25 | — | — | US | disclosed |
| US-20100009934-A1 | BETA ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF B-CELL PROLIFERATIVE DISORDERS | COMBINATORX, INCORPORATED (US) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009934-A1 | BETA ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF B-CELL PROLIFERATIVE DISORDERS | ADRB1, ADRB2, ADRA2B | ADRB2 2/4885TSHR 399/4885HIF1A 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.